Advanced Biomed is trading 8.4% down at $7.33 as its multi-day selloff persists following the cancellation of a planned securities offering.
- The stock has lost more than half of its value over the past week as investors react to the scrapped funding plans and potential capital constraints.
- Renewed downside emerged during recent trading sessions as market participants reassess dilution risks and future funding strategies.
- The bearish momentum continues despite broadly firmer index futures, signaling a specific shift in risk appetite regarding the company's outlook.